For decades, Botulinum toxin type A—widely recognized by the brand name Botox—has been the gold standard for...
Boston Scientific, a titan in the global medical technology landscape, has found itself at a strategic crossroads....
[City, State] – [Date] – Within the bustling headquarters of the National Breast Cancer Foundation (NBCF), a...
As the international community converges for the 26th International AIDS Conference (AIDS 2026), the World Health Organization...
ROCKVILLE, MD — In a move set to reshape the landscape of genetic research dissemination, the American...
By Madison Decker, Charitable Advancement Manager, National Breast Cancer Foundation (NBCF) With additional contributions from Katie Mooneyham,...
A multi-year collaboration between global clinical research organization (CRO) ICON plc and leading artificial intelligence company Anthropic...
By Gwendolyn Wu Published July 29, 2026 In a rapidly shifting landscape for life sciences, the traditional...
The landscape of breast cancer treatment in the European Union is undergoing a significant transformation. In a...
Introduction: A Sanctuary in the Clinical In the sterile, high-stakes environment of an oncology infusion center, the...
